Edward M. Newman

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.

Kevin J. Scanlon, Edward M. Newman, Yuzhi Lu et al. · Proceedings of the National Academy of Sciences · 1986 · 369 citations

Medicine, Oncology, Pharmacology +16

Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Mark Kirschbaum, Paul Frankel, Leslie Popplewell et al. · Journal of Clinical Oncology · 2011 · 212 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

CD30 Downregulation, MMAE Resistance, and <i>MDR1</i> Upregulation Are All Associated with Resistance to Brentuximab Vedotin

Robert Chen, Jessie Hou, Edward M. Newman et al. · Molecular Cancer Therapeutics · 2015 · 210 citations · Full text

Medicine, Oncology, Pharmacology +13

A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

Shivaani Kummar, Jiuping Ji, Robert J. Morgan et al. · Clinical Cancer Research · 2012 · 201 citations · Full text

Medicine, Oncology, Pharmacology +17

Mechanism of human methyl-directed DNA methyltransferase and the fidelity of cytosine methylation.

Steven S. Smith, Bruce E. Kaplan, Lawrence C. Sowers et al. · Proceedings of the National Academy of Sciences · 1992 · 149 citations

Life Sciences, Biochemistry, Genetics +14